To understand why this is safe, you have to look at how it works
Hypoglycemia Despite having a pronounced anti-hyperglycemic effect, GLP-1 RAs are not typically associated with hypoglycemia when used as monotherapy
Side effects are rare and typically mild, such as occasional skin sensitivity or temporary redness during the introductory phase, particularly at higher concentrations
however, there were no significant differences observed in the outcomes of requiring amputation and revascularization
It may be worth experimenting with timing, under the guidance of a healthcare provider, to manage side effects
As of now, no drugmaker has an early-stage migraine-specific GLP-1 drug program, according to publicly available information